Sport Milan coach Bonera tests positive for COVID-19, must sit out derby
States set to reopen as virus cases fall
Australia's COVID-19 case numbers continue to track in the right direction, paving the way for states to allow greater travel and ease other restrictions.
Daniele Bonera will be absent for Saturday's derby against Inter after the Milan assistant coach tested positive for COVID-19.
It was announced on Tuesday that Bonera, a former centre-back for the Rossoneri, tested positive after feeling unwell.
Milan said in a statement: "Daniele Bonera, following a rising fever, underwent a swab test yesterday at home, which has since returned a positive test for COVID-19.
Major incoming transfers by Italy's Serie A clubs
Major incoming transfers by Italy's Serie A clubsATALANTA (2019-20 Serie A: Third)
"Bonera is currently at home and is in a good condition. All of the other swab tests taken from the squad yesterday have returned negative results."
Video: Blood Red: Liverpool's UEFA Champions League Group confirmed | Ajax, Atalanta, FC Midtjylland (Liverpool Echo)
With Bonera in isolation, he will be missing from Stefano Pioli's coaching team when Milan tackle Inter in the first derby between the teams in the 2020-21 Serie A season.
Bonera also stands to be absent when Milan begin their Europa League campaign next week with a trip to face Scottish champions Celtic on Thursday, October 22.
Italian rules state that anyone that tests positive must stay in quarantine for at least 10 days and must have a negative result before being allowed to leave isolation.
Milan were boosted ahead of the derby when Zlatan Ibrahimovic was last week declared clear of coronavirus after returning two negative tests.
The 39-year-old striker contracted COVID-19 in September and missed four games for Milan.
Countries turn to rapid antigen tests to contain second wave of COVID-19 .
Countries turn to rapid antigen tests to contain second wave of COVID-19ZURICH/BERLIN (Reuters) - Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those infected quickly.